Gavi gains new partners at World Economic Forum

in page functions

Four private sector partnerships announced in Davos

Rising to a Global Challenge: The 15th Anniversary of Gavi: Seth F. Berkley

Gavi CEO, Seth Berkley at the Annual Meeting 2015 of the World Economic Forum in Davos.
Credit: World Economic Forum (CC BY-NC-SA 2.0).

Davos, 23 January 2015 - Gavi, the Vaccine Alliance has always provided a unique opportunity for the private sector to get engaged in the business of saving lives. From working with Gavi to reduce the cost of vaccines, to providing volunteers and expertise, the private sector has proved instrumental in Gavi’s efforts to immunise more than 500 million children against vaccine-preventable diseases in the last 15 years.

At the World Economic Forum in Davos this week, the Vaccine Alliance announced three new, exciting partnerships. Here’s a quick rundown of the new partners and the added value and skills they bring to the Vaccine Alliance:

UPSUPS

UPS, the global logistics provider, will work with Gavi to leverage the expertise of its Global Healthcare Logistics Strategy Group to develop and implement an executive training and mentorship programme to enhance the capability of local supply chain leaders who will go on to build robust immunisation supply chains.

IFPW

International Federation of Pharmaceutical Wholesalers (IFPW)

A three-year partnership between Gavi and IFPW, a global association of pharmaceutical wholesalers focused on the storage and delivery of medicines, to bolster regional supply chain training centres in Benin and Rwanda though a packet of support including US$ 1.5 million in cash and member expertise.

Star SyringeStar Syringe

A new collaboration with Star Syringe, a UK-based medical research, design and development company, to leverage royalties on the company’s patented K1 auto-disposable syringe, which will provide up to US$ 2 million in cost savings to Gavi and developing countries.

HMDHindustan Syringes & Medical Devices (HMD)

An agreement by the Indian company HMD to bring local knowledge and technical expertise, valued at up to US $1.5 million, in support of an upcoming WHO global injection safety campaign

close icon

modal window here